Skip to main content
. 2019 Feb 19;7(2):54. doi: 10.3390/microorganisms7020054

Table 4.

HPyV prevalence among patients.

HPyVs
Patients (n) BKPyV+/Tot *,**
(%)
MCPyV+/Tot **
(%)
HPyV-6+/Tot *
(%)
126 1/126 *,**
(0.8)
28/126 *,**
(23.0)
5/126 *
(4.8)

*= p < 0.0001; ** = p ≤ 0.001, Tot: Total.